Preparation, evaluation, and first clinical use of <sup>177</sup>Lu‐labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacySudipta Chakraborty, Ashutosh Dash, A. Rajeswari et al.|Journal of Labelled Compounds and Radiopharmaceuticals|2014Cited by 28